Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

Lynn G. Feun,Christopher B O'Brien,Enrique G. Molina,Miguel J. Rodriguez,Lj Jeffers,Eugene R. Schiff,Angela Marini,Niramol Savaraj,Bach Ardalan

Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial

2003

Lynn G. Feun
Christopher B O'Brien
Enrique G. Molina
Miguel J. Rodriguez
Lj Jeffers
Eugene R. Schiff
Angela Marini
Niramol Savaraj
Bach Ardalan

Purpose. To study the combination of 5FUDR, recombinant leukocyte interferon (IFN), and doxorubicin in patients with unresectable hepatocellular carcinoma.

Keywords:

Immunology
Interferon alfa
Alpha interferon
Immunotherapy
Hepatocellular carcinoma
Interferon
Doxorubicin
Cancer research
Recombinant DNA
Chemotherapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations